GlassScriptPhysician profile
Syed Siddiqullah
NPI 1518693035
$735.29
in general payments reported to CMS, 2019-2025
10 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $138 · 2024: $417 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $735.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $215.47 | 2024-2025 | Barostim Neo System |
| Abbott Laboratories | $146.56 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Inari Medical, INC. | $137.72 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $82.60 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.00 | 2024-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $29.79 | 2025 | Farxiga, Lokelma |
| Kestra Medical Technology Services, INC. | $29.39 | 2024 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $16.87 | 2025 | Amvuttra |
| Merck Sharp & Dohme LLC | $16.25 | 2024 | Verquvo |
| Itamar Medical INC | $14.64 | 2025 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Siddiqullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.